eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

4/2018
vol. 43
 
Share:
Share:
more
 
 
abstract:
Case report

A case of recurrent Mikulicz’s disease with mononeuritis multiplex

Atsushi Mizuma, Maiko Kouchi, Chikage Kijima, Sachiko Yutani, Tsuyoshi Uesugi, Eiichiro Nagata, Shunya Takizawa

(Centr Eur J Immunol 2018; 43 (4): 490-494)
Online publish date: 2018/12/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
We report an 82-year-old man with recurrence of Mikulicz’s disease accompanied with mononeuritis multiplex. On admission, both upper eyelids, the salivary gland, the dorsum of the left hand and both legs were swollen. Neurological examination showed motor weakness of distal limbs (manual muscle testing 3/5) and decreased touch, pain and vibration sensation of the dorsum of the left hand and both legs. Deep tendon reflex in both legs was also decreased. We diagnosed Mikulicz’s disease based on high serum immunoglobulin (Ig)G4 (630 mg/dl, 26.1% of total IgG) and lacrimal gland biopsy findings. Clinical symptoms and motor conduction study findings improved after steroid therapy. However, tapering of the steroid dose resulted in recurrence two years later. Steroid therapy is usually effective for IgG4-related neuropathy, and we found that an increase of steroid dose was effective to treat the recurrence. But, in general, a suitable maintenance dose of steroid in combination with an immunosuppressant may be necessary to prevent relapse.
keywords:

Mikulicz’s disease, mononeuritis multiplex, IgG4, steroid therapy

references:
Hamano H, Kawa S, Horiuchi A, et al. (2001): High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344: 732-738.
Umehara H, Okazaki K, Masaki Y, et al. (2012): Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22: 1-14.
Okazaki K, Uchida K, Ohana M, et al. (2000): Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118: 573-581.
Umehara H, Okazaki K, Masaki Y, et al. (2012): Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22: 21-30.
Kamisawa T, Okamoto A (2006): Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 41: 613-625.
Kamisawa T, Zen Y, Pillai S, Stone JH (2015): IgG4-related disease. Lancet 385: 1460-1471.
Kupersmith MJ, Martin V, Heller G, et al. (2004): Idiopathic hypertrophyic pachymeningitis. Neurology 62: 686-694.
Shimatsu A, Oki Y, Fujisawa I, Sano T (2009): Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immune G4-related systemic disease: an emerging clinical entity. Endocr J 56: 1033-1041.
Ohyama K, Koike H, Iijima M, et al. (2013): IgG4-related neuropathy: a case report. JAMA Neurol 70: 502-505.
Yamamoto M, Takahashi H, Ohara M, et al. (2006): A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol 16: 335-340.
Yamamoto M, Takahashi H, Suzuki C, et al. (2010): Analysis of serum IgG subclasses in Churg-Strauss syndrome – the meaning of elevated serum levels of IgG4. Intern Med 49: 1365-1370.
Yamamoto M, Takahashi H, Shinomura Y (2011): Mikulicz’s disease and the extraglandular lesions. Curr Immunol Rev 7: 162-171.
Kawa S, Okazaki K, Kamisawa T, et al. (2014): Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol 49: 961-970.
Kamisawa T, Okazaki K, Kawa S, et al. (2009): Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by the Ministry of Health, Labour and Welfare of Japan. Standard steroid treatment for autoimmune pancreatitis. Gut 58: 1504-1507.
Ghazale A, Chari ST, Zhang L, et al. (2008): Immunogloblin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 134: 706-715.
Sogabe Y, Ohshima K, Azumi A, et al. (2014): Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol 252: 531-538.
Shimosegawa T, Okazaki K, Kamisawa T, et al. (2011): International consensus diagnostic criteria for autoimmune pancreatitis. Guidelines of the International Association of Pancreatology. Pancreas 40: 352-358.
Raina A, Yadav D, Krasinskas AM, et al. (2009): Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 104: 2295-2306.
Yamamoto M, Nojima M, Takahashi H, et al. (2015): Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment. Rheumatology(Oxford) 54: 45-49.
Saeki T, Kawano M, Mizushima I, et al. (2013): The clinical course of patients with IgG4-related kidney disease. Kidney Int 84: 826-833.
Hagiya C, Tsuboi H, Yokosawa M, et al. (2014): Clinicopathological features of IgG4-related disease complicated with orbital involvement. Mod Rheumatol 24: 471-476.
Hart PA, Topazian MD, Witzig TE, et al. (2013): Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 62: 1607-1615.
Khosroshahi A, Carruthers MN, Deshpande V, et al. (2012): Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 91: 57-66.
FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe